表紙
市場調查報告書

嬰兒用配方奶粉益生元的全球市場 - 產業趨勢與預測

Global Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027

出版商 Data Bridge Market Research Private Limited 商品編碼 921306
出版日期 內容資訊 英文 301 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
嬰兒用配方奶粉益生元的全球市場 - 產業趨勢與預測 Global Prebiotics for Infant Formula Market - Industry Trends and Forecast To 2027
出版日期: 2019年12月01日內容資訊: 英文 301 Pages
簡介

全球嬰兒用配方奶粉益生元市場在2020年∼2027年的預測期間內,預計將達到相當的年複合成長率。

本報告提供全球嬰兒用配方奶粉益生元市場相關調查分析,提供市場概要,各市場區隔的市場分析,各地區的市場分析,競爭情形,主要企業等相關的系統性資訊。

目錄

第1章 簡介

第2章 市場區隔

第3章 摘要整理

第4章 重要考察

第5章 演進

  • 嬰兒用配方奶粉的演進
  • 益生元配方奶粉的演進

第6章 法規和品質必要條件

  • 規則
  • 品質必要條件

第7章 臨床試驗

  • NCT03994315
  • NCT03884309
  • NCT02594683
  • NCT03661736
  • NCT03666572
  • NCT03866837
  • NCT03476889

第8章 嬰兒用配方奶粉品牌分析師

  • ABBOTT
  • MEAD JOHNSON & COMPANY, LLC
  • DANONE NUTRICIA
  • NESTLE
  • PERRIGO NUTRITIONALS
  • HOCHDORF HOLDING AG

第9章 市場概要

  • 促進因素
  • 阻礙因素
  • 市場機會
  • 課題

第10章 全球嬰兒用配方奶粉益生元市場:各類型

  • 概要
  • 母乳寡糖(HMOS)
  • 果寡糖(FOS)
  • 半乳寡糖(GOS)
  • 菊糖
  • 多糊精(PDX)
  • 甘露聚醣(MOS)
  • 乳糖(LOS)

第11章 全球嬰兒用配方奶粉益生元市場:各來源

  • 概要
  • 植物·蔬菜
  • 細菌
  • 菌類
  • 藻類
  • 其他

第12章 全球嬰兒用配方奶粉益生元市場:各等級

  • 概要
  • 無機
  • 有機

第13章 全球嬰兒用配方奶粉益生元市場:不同形態

  • 概要
  • 粉末
  • 液體

第14章 全球嬰兒用配方奶粉益生元市場:各產品類型

  • 概要
  • 標準處方
  • 特殊處方
  • 後續
  • 幼兒用

第15章 全球嬰兒用配方奶粉益生元市場:各嬰兒年齡

  • 概要
  • 6∼12個月
  • 0∼6個月
  • 1∼3歲

第16章 全球嬰兒用配方奶粉益生元市場:各地區

  • 概要
  • 北美
  • 亞太地區
  • 歐洲
  • 南美
  • 中東·非洲

第17章 全球嬰兒用配方奶粉益生元市場:企業形勢

  • 企業佔有率分析:世界
  • 企業佔有率分析:北美
  • 企業佔有率分析:亞太地區
  • 企業佔有率分析:歐洲
  • 企業佔有率分析:中東·非洲地區

第18章 企業簡介

  • ROYAL FRIESLANDCAMPINA N.V.
  • CARGILL, INCORPORATED
  • INGREDION INCORPORATED
  • BENEO
  • FONTERRA CO-OPERATIVE GROUP
  • BIOSYNTH CARBOSYNTH
  • COSUCRA
  • DANA DAIRY GROUP
  • DEXTRA LABORATORIES LIMITED
  • DUPONT
  • ELICITYL SA
  • GLYCOM A/S
  • GLYCOSYN LLC
  • JENNEWEIN BIOTECHNOLOGIE GMBH
  • NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED
  • ROYAL COSUN
  • TEREOS
  • ZUCHEM INC.

第19章 詢問調查

第20章 相關報告

目錄

Global prebiotics for infant formula market is projected to register a substantial CAGR in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation

By Type (Human Milk Oligosaccharides (HMOS), Galactooligosaccharides (GOS), Fructooligosaccharides (FOS), Mannan-Oligosaccharides (MOS), Polydextrose (PDX), Lactulose (LOS), Inulin), Source (Bacteria, Algae, Fungi, Plants & Vegetables), Grade (Inorganic, Organic), Form (Powder, Liquid), Product Type (Standard Formula, Toddler Formula, Follow Up Formula, Special Formula), Infant Age (0-6 Months, 6-12 Months, 1-3 Years), By Geography (North America, Asia-Pacific, Europe, South America, Middle East & Africa), Market Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global prebiotics for infant formula market:

  • Rising Number from Preterm/Premature Babies
  • Increased Research Initiative for New Product Development

Key Market Players

The key market players for global prebiotics for infant formula market are listed below:

  • Jennewein Biotechnologie GmbH
  • zuChem Inc
  • Biosynth Carbosynth
  • ElicitylSA
  • Dextra Laboratories Limited
  • Glycom A/S
  • Tereos
  • Ingredion Incorporated
  • Royal FrieslandCampina N.V
  • Sudzucker AG
  • Cargill, Incorporated
  • Fonterra Co-operative Group
  • Royal Cosun
  • COSUCRA
  • New Francisco (Yunfu City) Biotechnology Corporation Limited
  • Dana Dairy Group
  • Glycosyn LLC
  • DuPont

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 OVERVIEW OF GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET
  • 1.4 CURRENCY AND PRICING
  • 1.5 LIMITATIONS
  • 1.6 MARKETS COVERED

2 MARKET SEGMENTATION

  • 2.1 MARKETS COVERED
  • 2.2 GEOGRAPHICAL SCOPE
  • 2.3 YEARS CONSIDERED FOR THE STUDY
  • 2.4 DBMR TRIPOD DATA VALIDATION MODEL
  • 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
  • 2.6 DBMR MARKET POSITION GRID
  • 2.7 MULTIVARIATE MODELING
  • 2.8 PRODUCT TIMELINE CURVE
  • 2.9 SECONDARY SOURCES
  • 2.10 ASSUMPTIONS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 EVOLUTION

  • 5.1 EVOLUTION OF INFANT FORMULA
  • 5.2 EVOLUTION OF PREBIOTICS FORMULA

6 REGULATIONS & QUALITY REQUIREMENTS

  • 6.1 REGULATIONS
    • 6.1.1 FDA
      • 6.1.1.1 GRAS NOTICE NO. GRN 000849
      • 6.1.1.2 GRAS NOTICE NO. GRN 00859
      • 6.1.1.3 GRAS NOTICE NO. GRN 000797
      • 6.1.1.4 GRAS NOTICE NO. GRN 000766
      • 6.1.1.5 GRAS Notice No. GRN 000749
      • 6.1.1.6 GRAS Notice No. GRN 000735
      • 6.1.1.7 GRAS Notice No. GRN 000729
      • 6.1.1.8 GRAS Notice No. GRN 000717
      • 6.1.1.9 GRAS Notice No. GRN 000721
      • 6.1.1.10 GRAS Notice No. GRN 000659
      • 6.1.1.11 GRAS Notice No. GRN 000650
      • 6.1.1.12 GRAS Notice No. GRN 000623
      • 6.1.1.13 GRAS Notice No. GRN 000620
    • 6.1.2 EUROPEAN UNION
      • 6.1.2.1 COMMISSION DIRECTIVE 2006/141/EC
    • 6.1.3 AUSTRALIA NEW ZEALAND FOOD STANDARDS CODE
      • 6.1.3.1 STANDARD 2.9.1
      • 6.1.3.2 STANDARD 2.9.2
      • 6.1.3.3 STANDARD 2.9.3
  • 6.2 QUALITY REQUIREMENTS

7 CLINICAL TRIALS

  • 7.1 NCT03994315
  • 7.2 NCT03884309
  • 7.3 NCT02594683
  • 7.4 NCT03661736
  • 7.5 NCT03666572
  • 7.6 NCT03866837
  • 7.7 NCT03476889

8 INFANT FORMULA BRAND ANALYSTS

  • 8.1 ABBOTT
  • 8.2 MEAD JOHNSON & COMPANY, LLC
  • 8.3 DANONE NUTRICIA
  • 8.4 NESTLE
  • 8.5 PERRIGO NUTRITIONALS
  • 8.6 HOCHDORF HOLDING AG

9 MARKET OVERVIEW

  • 9.1 DRIVERS
    • 9.1.1 RISING NUMBER FROM PRETERM/PREMATURE BABIES
    • 9.1.2 INCREASED RESEARCH INITIATIVE FOR NEW PRODUCT DEVELOPMENT
    • 9.1.3 HEALTH BENEFITS ASSOCIATED WITH PREBIOTICS
    • 9.1.4 GROWING CONCERN AND DEMAND FOR THE HEALTHY BABY FOOD
    • 9.1.5 RISING POPULATION OF INFANT
  • 9.2 RESTRAINTS
    • 9.2.1 STRINGENT REGULATION AND APPROVAL CRITERIA SET BY GOVERNMENTS
    • 9.2.2 RISING AWARENESS TOWARDS MOTHER FEEDING FOR INFANT
  • 9.3 OPPORTUNITIES
    • 9.3.1 RAPID DEVELOPMENT IN CHICORY ROOT BASED PREBIOTICS
    • 9.3.2 EMERGING DEMAND IN DEVELOPING NATIONS
    • 9.3.3 STRENGTHENING TRADE RELATIONSHIP BETWEEN DIFFERENT NATIONS
  • 9.4 CHALLENGE
    • 9.4.1 RISING NUMBER OF PRODUCT RECALLS FOR INFANT FORMULA DUE TO CONTAMINATION

10 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY TYPE

  • 10.1 OVERVIEW
  • 10.2 HUMAN MILK OLIGOSACCHARIDES (HMOS)
    • 10.2.1 FUCOSYLLACTOSE
      • 10.2.1.1 NEUTRAL FUCOSYLATE OLIGOSACCHARIDES
      • 10.2.1.2 NON-FUCOSYLATED OLIGOSACCHARIDES
    • 10.2.2 LACTO-N- TETRAOSE (LNT) & LACTO-N-NEOTETRAOSE (LNNT)
    • 10.2.3 SIALYLLACTOSE
  • 10.3 FRUCTOOLIGOSACCHARIDES (FOS)
    • 10.3.1 LONG CHAIN FOS (LCFOS)
    • 10.3.2 SINGLE CHAIN FOS (SCFOS)
  • 10.4 GALACTOOLIGOSACCHARIDES (GOS)
    • 10.4.1 LACTOSE DERIVED
    • 10.4.2 GALACTOSE DERIVED
  • 10.5 INULIN
  • 10.6 POLYDEXTROSE (PDX)
  • 10.7 MANNAN-OLIGOSACCHARIDES (MOS)
  • 10.8 LACTULOSE (LOS)

11 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY SOURCE

  • 11.1 OVERVIEW
  • 11.2 PLANTS & VEGETABLES
    • 11.2.1 WHEAT
    • 11.2.2 CHICORY ROOT
    • 11.2.3 BANANAS
    • 11.2.4 LEEKS
    • 11.2.5 TOMATOES
    • 11.2.6 OTHERS
  • 11.3 BACTERIA
  • 11.4 FUNGI
  • 11.5 ALGAE
  • 11.6 OTHERS

12 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY GRADE

  • 12.1 OVERVIEW
  • 12.2 INORGANIC
  • 12.3 ORGANIC

13 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY FORM

  • 13.1 OVERVIEW
  • 13.2 POWDER
  • 13.3 LIQUID

14 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY PRODUCT TYPE

  • 14.1 OVERVIEW
  • 14.2 STANDARD FORMULA
  • 14.3 SPECIAL FORMULA
  • 14.4 FOLLOW UP FORMULA
  • 14.5 TODDLER FORMULA

15 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY INFANT AGE

  • 15.1 OVERVIEW
  • 15.2 6-12 MONTHS
  • 15.3 0-6 MONTHS
  • 15.4 1-3 YEARS

16 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY GEOGRAPHY

  • 16.1 OVERVIEW
  • 16.2 NORTH AMERICA
    • 16.2.1 U.S.
    • 16.2.2 CANADA
    • 16.2.3 MEXICO
  • 16.3 ASIA-PACIFIC
    • 16.3.1 JAPAN
    • 16.3.2 CHINA
    • 16.3.3 SOUTH KOREA
    • 16.3.4 INDIA
    • 16.3.5 AUSTRALIA
    • 16.3.6 SINGAPORE
    • 16.3.7 MALAYSIA
    • 16.3.8 THAILAND
    • 16.3.9 INDONESIA
    • 16.3.10 PHILIPPINES
    • 16.3.11 NEW ZEALAND
    • 16.3.12 VIETNAM
    • 16.3.13 REST OF ASIA-PACIFIC
  • 16.4 EUROPE
    • 16.4.1 GERMANY
    • 16.4.2 U.K.
    • 16.4.3 FRANCE
    • 16.4.4 ITALY
    • 16.4.5 SPAIN
    • 16.4.6 DENMARK
    • 16.4.7 NETHERLANDS
    • 16.4.8 SWITZERLAND
    • 16.4.9 POLAND
    • 16.4.10 RUSSIA
    • 16.4.11 SWEDEN
    • 16.4.12 BELGIUM
    • 16.4.13 TURKEY
    • 16.4.14 REST OF EUROPE
  • 16.5 SOUTH AMERICA
    • 16.5.1 BRAZIL
    • 16.5.2 ARGENTINA
    • 16.5.3 REST OF SOUTH AMERICA
  • 16.6 MIDDLE EAST & AFRICA
    • 16.6.1 SOUTH AFRICA
    • 16.6.2 U.A.E.
    • 16.6.3 SAUDI ARABIA
    • 16.6.4 OMAN
    • 16.6.5 KUWAIT
    • 16.6.6 REST OF MIDDLE EAST & AFRICA

17 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, COMPANY LANDSCAPE

  • 17.1 COMPANY SHARE ANALYSIS: GLOBAL
  • 17.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
  • 17.3 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
  • 17.4 COMPANY SHARE ANALYSIS: EUROPE
  • 17.5 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA

18 COMPANY PROFILE

  • 18.1 ROYAL FRIESLANDCAMPINA N.V.
    • 18.1.1 COMPANY SNAPSHOT
    • 18.1.2 REVENUE ANALYSIS
    • 18.1.3 COMPANY SHARE ANALYSIS
    • 18.1.4 PRODUCT PORTFOLIO
    • 18.1.5 RECENT DEVELOPMENTS
  • 18.2 CARGILL, INCORPORATED.
    • 18.2.1 COMPANY SNAPSHOT
    • 18.2.2 REVENUE ANALYSIS
    • 18.2.3 COMPANY SHARE ANALYSIS
    • 18.2.4 PRODUCT PORTFOLIO
    • 18.2.5 RECENT DEVELOPMENT
  • 18.3 INGREDION INCORPORATED
    • 18.3.1 COMPANY SNAPSHOT
    • 18.3.2 REVENUE ANALYSIS
    • 18.3.3 COMPANY SHARE ANALYSIS
    • 18.3.4 PRODUCT PORTFOLIO
    • 18.3.5 RECENT DEVELOPMENT
  • 18.4 BENEO (A SUBSIDIARY OF SUDZUCKER)
    • 18.4.1 COMPANY SNAPSHOT
    • 18.4.2 REVENUE ANALYSIS
    • 18.4.3 COMPANY SHARE ANALYSIS
    • 18.4.4 PRODUCT PORTFOLIO
    • 18.4.5 RECENT DEVELOPMENTS
  • 18.5 FONTERRA CO-OPERATIVE GROUP
    • 18.5.1 COMPANY SNAPSHOT
    • 18.5.2 REVENUE ANALYSIS
    • 18.5.3 COMPANY SHARE ANALYSIS
    • 18.5.4 PRODUCT PORTFOLIO
    • 18.5.5 RECENT DEVELOPMENTS
  • 18.6 BIOSYNTH CARBOSYNTH
    • 18.6.1 COMPANY SNAPSHOT
    • 18.6.2 PRODUCT PORTFOLIO
    • 18.6.3 RECENT DEVELOPMENTS
  • 18.7 COSUCRA
    • 18.7.1 COMPANY SNAPSHOT
    • 18.7.2 PRODUCT PORTFOLIO
    • 18.7.3 RECENT DEVELOPMENTS

  • 18.8 DANA DAIRY GROUP
    • 18.8.1 COMPANY SNAPSHOT
    • 18.8.2 PRODUCT PORTFOLIO
    • 18.8.3 RECENT DEVELOPMENTS
  • 18.9 DEXTRA LABORATORIES LIMITED
    • 18.9.1 COMPANY SNAPSHOT
    • 18.9.2 PRODUCT PORTFOLIO
    • 18.9.3 RECENT DEVELOPMENT
  • 18.10 DUPONT.
    • 18.10.1 COMPANY SNAPSHOT
    • 18.10.2 REVENUE ANALYSIS
    • 18.10.3 PRODUCT PORTFOLIO
    • 18.10.4 RECENT DEVELOPMENTS
  • 18.11 ELICITYL SA
    • 18.11.1 COMPANY SNAPSHOT
    • 18.11.2 PRODUCT PORTFOLIO
    • 18.11.3 RECENT DEVELOPMENT
  • 18.12 GLYCOM A/S
    • 18.12.1 COMPANY SNAPSHOT
    • 18.12.2 PRODUCT PORTFOLIO
    • 18.12.3 RECENT DEVELOPMENT
  • 18.13 GLYCOSYN LLC.
    • 18.13.1 COMPANY SNAPSHOT
    • 18.13.2 PRODUCT PORTFOLIO
    • 18.13.3 RECENT DEVELOPMENTS
  • 18.14 JENNEWEIN BIOTECHNOLOGIE GMBH
    • 18.14.1 COMPANY SNAPSHOT
    • 18.14.2 PRODUCT PORTFOLIO
    • 18.14.3 RECENT DEVELOPMENTS
  • 18.15 NEW FRANCISCO (YUNFU CITY) BIOTECHNOLOGY CORPORATION LIMITED
    • 18.15.1 COMPANY SNAPSHOT
    • 18.15.2 PRODUCT PORTFOLIO
    • 18.15.3 RECENT DEVELOPMENTS
  • 18.16 ROYAL COSUN
    • 18.16.1 COMPANY SNAPSHOT
    • 18.16.2 REVENUE ANALYSIS
    • 18.16.3 APPLICATION PORTFOLIO
    • 18.16.4 RECENT DEVELOPMENT

  • 18.17 TEREOS
    • 18.17.1 COMPANY SNAPSHOT
    • 18.17.2 REVENUE ANALYSIS
    • 18.17.3 PRODUCT PORTFOLIO
    • 18.17.4 RECENT DEVELOPMENT
  • 18.18 ZUCHEM INC.
    • 18.18.1 COMPANY SNAPSHOT
    • 18.18.2 PRODUCT PORTFOLIO
    • 18.18.3 RECENT DEVELOPMENT

19 QUESTIONNAIRE

20 RELATED REPORTS

LIST OF FIGURES

  • FIGURE 1 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 2 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DATA TRIANGULATION
  • FIGURE 3 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DROC ANALYSIS
  • FIGURE 4 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
  • FIGURE 5 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY RESEARCH ANALYSIS
  • FIGURE 6 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: INTERVIEW DEMOGRAPHICS
  • FIGURE 7 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DBMR MARKET POSITION GRID
  • FIGURE 8 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: DBMR VENDOR SHARE ANALYSIS
  • FIGURE 9 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SEGMENTATION
  • FIGURE 10 STRINGENT REGULATIONS SET BY GOVERNMENT FOR FOOD & DRUG DEVELOPMENT IS EXPECTED TO DRIVE THE GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET IN THE FORECAST PERIOD OF 2020 TO 2027
  • FIGURE 11 HUMAN MILK OLIGOSACCHARIDES (HMOS) IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET IN 2020 & 2027
  • FIGURE 12 TO ENSURE THE QUALITY, THE MANUFACTURERS CAN IMPLEMENT THE FOLLOWING QUALITY STANDARDS PROCEDURE OR STEPS:
  • FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITY AND CHALLENGE OF GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET
  • FIGURE 14 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE, 2019
  • FIGURE 15 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY SOURCE, 2019
  • FIGURE 16 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GRADE, 2019
  • FIGURE 17 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY FORM, 2019
  • FIGURE 18 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY PRODUCT TYPE, 2019
  • FIGURE 19 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY INFANT AGE, 2019
  • FIGURE 20 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 21 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2019)
  • FIGURE 22 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2020 & 2027)
  • FIGURE 23 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY GEOGRAPHY (2019 & 2027)
  • FIGURE 24 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 25 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET, BY REGION, 2018-2027 (USD MILLION)
  • FIGURE 26 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 27 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 28 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 29 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 30 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 31 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 32 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 33 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 34 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 35 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 36 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 37 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 38 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 39 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 40 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 41 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 42 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 43 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 44 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 45 SOUTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 46 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: SNAPSHOT (2019)
  • FIGURE 47 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019)
  • FIGURE 48 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2020 & 2027)
  • FIGURE 49 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY COUNTRY (2019 & 2027)
  • FIGURE 50 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: BY TYPE (2020-2027)
  • FIGURE 51 GLOBAL PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 52 NORTH AMERICA PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 53 EUROPE PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 54 ASIA-PACIFIC PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
  • FIGURE 55 MIDDLE EAST & AFRICA PREBIOTICS FOR INFANT FORMULA MARKET: COMPANY SHARE 2019 (%)
Back to Top